The fibrinolytic enzyme system in hypertension
Open Access
- 1 May 1973
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 26 (5), 351-353
- https://doi.org/10.1136/jcp.26.5.351
Abstract
Fibrinogen, fibrinogen-related antigen (FR-antigen), and components of the fibrinolytic enzyme system were measured in patients with essential hypertension, renal disease with and without hypertension, and normal subjects. Essential hypertension was associated with a decrease in plasminogen activator and an increase in FR-antigen. In renal disease these changes were accompanied by increases in plasminogen activation inhibitor, alpha2-macroglobulin, alpha1-antitrypsin, and fibrinogen.Keywords
This publication has 18 references indexed in Scilit:
- Inhibitors of the Fibrinolytic Enzyme System in Renal DiseaseClinical Science, 1970
- Study of Proteins and Fibrinolysis in Patients with GlomerulonephritisBMJ, 1970
- MICROANGIOPATHIC HÆMOLYTIC ANÆMIA AND THE PATHOGENESIS OF MALIGNANT HYPERTENSIONThe Lancet, 1969
- Split products of fibrin in human renal diseaseThe American Journal of Medicine, 1969
- Plasma fibrinogen and plasminogen levels in health and in ischaemic heart diseaseJournal of Clinical Pathology, 1966
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- The coagulation process and glomerular diseaseThe American Journal of Medicine, 1965
- SIGNIFICANCE OF CRYOPROFIBRIN IN FIBRINOGEN-FIBRIN CONVERSIONThe Journal of Experimental Medicine, 1962
- THE MECHANISM OF CLOT DISSOLUTION BY PLASMIN*Journal of Clinical Investigation, 1959
- STUDIES ON ENHANCED FIBRINOLYTIC ACTIVITY IN MAN*Journal of Clinical Investigation, 1959